ProfessorsProfessors of Johns Hopkins UniversityNoton Kumar Dutta

Noton Kumar Dutta

Johns Hopkins University

H-index: 37

North America-United States

About Noton Kumar Dutta

Noton Kumar Dutta, With an exceptional h-index of 37 and a recent h-index of 24 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Tuberculosis Research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?

The anti-tubercular activity of simvastatin is mediated by cholesterol-dependent regulation of autophagy via the AMPK-mTORC1-TFEB axis

The nucleocapsid protein of SARS–CoV-2: a target for vaccine development

Accelerating drug development through repurposed FDA approved drugs for COVID-19: speed is important, not haste

Antibiotic treatment shapes the antigenic environment during chronic TB infection, offering novel targets for therapeutic vaccination

Noton Kumar Dutta Information

University	Johns Hopkins University
Position	___
Citations(all)	4108
Citations(since 2020)	2064
Cited By	2844
hIndex(all)	37
hIndex(since 2020)	24
i10Index(all)	67
i10Index(since 2020)	42
Email	Access Email
University Profile Page	Johns Hopkins University
Google Scholar	View Google Scholar Profile

Noton Kumar Dutta Skills & Research Interests

Tuberculosis Research

Top articles of Noton Kumar Dutta

Title	Journal	Author(s)	Publication Date
Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?	Frontiers in Immunology	Noton K Dutta Bianca E Schneider	2020
The anti-tubercular activity of simvastatin is mediated by cholesterol-dependent regulation of autophagy via the AMPK-mTORC1-TFEB axis	Journal of lipid research	Natalie Bruiners Noton K Dutta Valentina Guerrini Hugh Salamon Ken D Yamaguchi ...	2020/12/1
The nucleocapsid protein of SARS–CoV-2: a target for vaccine development	Journal of virology	Noton K Dutta Kaushiki Mazumdar James T Gordy	2020/7
Accelerating drug development through repurposed FDA approved drugs for COVID-19: speed is important, not haste	Antimicrobial Agents and Chemotherapy	James T Gordy Kaushiki Mazumdar Noton K Dutta	2020/5/18
Antibiotic treatment shapes the antigenic environment during chronic TB infection, offering novel targets for therapeutic vaccination	Frontiers in immunology	Yu-Min Chuang Noton K Dutta James T Gordy Victoria L Campodónico Michael L Pinn ...	2020/4/28